Concordance in salivary cortisol and subjective anxiety to the trier social stress test in social anxiety disorder.


Journal

Biological psychology
ISSN: 1873-6246
Titre abrégé: Biol Psychol
Pays: Netherlands
ID NLM: 0375566

Informations de publication

Date de publication:
11 2022
Historique:
received: 25 10 2021
revised: 06 10 2022
accepted: 10 10 2022
pubmed: 18 10 2022
medline: 24 11 2022
entrez: 17 10 2022
Statut: ppublish

Résumé

Social anxiety disorder (SAD) is characterised by an excessive fear of negative social evaluation. There is a limited understanding of how individuals with SAD react physiologically and subjectively to social stress. The Trier Social Stress Test (TSST), an acute social stress task, was completed by 40 SAD individuals (50% female) and 41 healthy controls (matched on age, sex, and education) to examine salivary cortisol and self-reported stress reactivity. Salivary cortisol concentrations and self-reported affect (anxiety, sadness, tiredness, withdrawal, and happiness) were assessed at baseline and across nine-time points during the TSST. Bayesian salivary cortisol analyses revealed no group differences in salivary cortisol levels at baseline or during the TSST, with results comparative after the removal of 17 cortisol non-responders (21%). Contrastingly, the groups significantly differed on self-reported affect. At baseline, the SAD group (vs. controls) reported heightened negative affect and diminished happiness. In response to the TSST, the SAD group (vs. controls) displayed greater negative affect reactivity and diminished happiness reactivity, and significantly higher rates of change in their anxiety and sadness over time. After accounting for differences in the temporal resolution of self-reported versus cortisol responses, a moderate positive association was found between salivary cortisol and anxiety reactivity to social stress that was comparable between the groups. Despite elevated subjective anxiety, our findings suggest concordance in psychobiological stress reactivity in SAD and healthy controls. We discuss the possibility of heightened subjective sensitivity to social evaluative stress as a core treatment target for SAD.

Sections du résumé

BACKGROUND
Social anxiety disorder (SAD) is characterised by an excessive fear of negative social evaluation. There is a limited understanding of how individuals with SAD react physiologically and subjectively to social stress.
METHOD
The Trier Social Stress Test (TSST), an acute social stress task, was completed by 40 SAD individuals (50% female) and 41 healthy controls (matched on age, sex, and education) to examine salivary cortisol and self-reported stress reactivity. Salivary cortisol concentrations and self-reported affect (anxiety, sadness, tiredness, withdrawal, and happiness) were assessed at baseline and across nine-time points during the TSST.
RESULTS
Bayesian salivary cortisol analyses revealed no group differences in salivary cortisol levels at baseline or during the TSST, with results comparative after the removal of 17 cortisol non-responders (21%). Contrastingly, the groups significantly differed on self-reported affect. At baseline, the SAD group (vs. controls) reported heightened negative affect and diminished happiness. In response to the TSST, the SAD group (vs. controls) displayed greater negative affect reactivity and diminished happiness reactivity, and significantly higher rates of change in their anxiety and sadness over time. After accounting for differences in the temporal resolution of self-reported versus cortisol responses, a moderate positive association was found between salivary cortisol and anxiety reactivity to social stress that was comparable between the groups.
CONCLUSIONS
Despite elevated subjective anxiety, our findings suggest concordance in psychobiological stress reactivity in SAD and healthy controls. We discuss the possibility of heightened subjective sensitivity to social evaluative stress as a core treatment target for SAD.

Identifiants

pubmed: 36252854
pii: S0301-0511(22)00187-9
doi: 10.1016/j.biopsycho.2022.108444
pii:
doi:

Substances chimiques

Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108444

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Caitlin Grace (C)

School of Behavioural & Health Sciences, Australian Catholic University, Melbourne, Australia. Electronic address: caitlin@SCMBH.com.au.

Markus Heinrichs (M)

School of Behavioural & Health Sciences, Australian Catholic University, Melbourne, Australia; Department of Psychology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Peter Koval (P)

Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia.

Alexandra Gorelik (A)

Monash Department of Clinical Epidemiology - Cabrini, Monash University, Melbourne, Australia; Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.

Bernadette von Dawans (B)

Department of Biological and Clinical Psychology, University of Trier, Trier, Germany.

Gill Terrett (G)

School of Behavioural & Health Sciences, Australian Catholic University, Melbourne, Australia.

Peter Rendell (P)

School of Behavioural & Health Sciences, Australian Catholic University, Melbourne, Australia.

Izelle Labuschagne (I)

School of Behavioural & Health Sciences, Australian Catholic University, Melbourne, Australia. Electronic address: izelle.labuschagne@acu.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH